Proceedings of the National Academy of Sciences

The Proceedings of the National Academy of Sciences of the United States of America, usually referred to as PNAS, is the official journal of the United States National Academy of Sciences (NAS). PNAS is an important scientific journal that printed its first issue in 1915 and continues to publish highly cited research reports, commentaries, reviews, perspectives, feature articles, profiles, letters to the editor, and actions of the Academy. Coverage in PNAS broadly spans the biological, physical, and social sciences. Although most of the papers published in the journal are in the biomedical sciences, PNAS recruits papers and publishes special features in the physical and social sciences and in mathematics. PNAS is published weekly in print, and daily online in PNAS Early Edition. PNAS was established by NAS in 1914, with its first issue published in 1915. The NAS itself had been founded in 1863 as a private institution, but chartered by the US Congress, with the goal to "investigate, examine, experiment, and report upon any subject of science or art." By 1914, the Academy was well established.

Publisher
United States National Academy of Sciences
Country
United States
History
1914 - present
Website
http://www.pnas.org/
Impact factor
9.681 (2011)

Some content from Wikipedia, licensed under CC BY-SA

Neuroscience

Study finds timing of brain waves shapes the words we hear

The timing of our brain waves shapes how we perceive our environment. We are more likely to perceive events when their timing coincides with the timing of relevant brain waves. Lead scientist Sanne ten Oever and her co-authors ...

Immunology

New drug shows promise in easing chronic pain, study finds

A team of researchers from Virginia Commonwealth University, the University of Texas at Austin and the University of Virginia have made progress toward developing a drug candidate for treating chronic pain more safely.

Immunology

Scientists discover a novel modulator of human regulatory T cells

The research group of Professor Riitta Lahesmaa have discovered a novel modulator for human regulatory T cells. This novel regulator can strengthen or dampen immune response and provides a new basis for therapeutic approaches ...

Medications

Study further illuminates ability of cancer drug to lower blood sugar

University of Oklahoma researchers have deepened their understanding of a drug's ability to prevent fat buildup in the liver, a condition that often occurs with obesity and can lead to serious fatty liver disease. Their findings—which ...

Medical research

Drug-like inhibitor shows promise in preventing flu

Currently available flu medications only target the virus after it has already established an infection, but what if a drug could prevent infection in the first place? Now, scientists at Scripps Research and the Albert Einstein ...

page 1 from 3